Condition
Respiratory Tract Infection Viral
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 3 (2)
P 4 (1)
Trial Status
Completed3
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07261969Not ApplicableRecruiting
CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan
NCT06743750CompletedPrimary
Comparison Between Different Sampling Sites for Detection of Respiratory Viruses
NCT05026801Phase 3WithdrawnPrimary
Azithromycin Plus Hydroxychloroquine for COVID-19 Infection
NCT04139681Phase 4Completed
Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats
NCT02971384Phase 3CompletedPrimary
Echinacea Junior vs Vitamin C in Children 4-12 Years Old
Showing all 5 trials